Culturing and Treating Cardiac Cell Lines
Corresponding Organization : University of Missouri
Protocol cited in 4 other protocols
Variable analysis
- β-blockers Aten, Met and Car
- Ang II
- Losartan (AT1R inhibitor)
- PD123319 (AT2R inhibitor)
- CGP42112a (partial AT2R agonist)
- SR59230A (β-3 AR specific blocker)
- U73122 (Phospholipase C inhibitor)
- Isoproterenol (β-AR activator)
- NP-6A4
- Not explicitly mentioned
- HL-1 cells were cultured at 37°C and 5% CO2
- HL-1 cells were grown on surfaces pre-treated with 12.5 μg/ml bovine fibronectin in 0.02% gelatin solution
- HL-1 cells were grown in Claycomb medium supplemented with Fetal Bovine Serum (10%), Penicillin/Streptomycin (100U/ml: 100mg/ml), Norepinephrine (100U/ml) and L-Glutamine (2mM)
- HCAVSMCs were cultured at 37°C and 5% CO2 in Medium 231 supplemented with Smooth Muscle Growth Supplement (SMGS)
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!